| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-05 | BlackRock Inc. | Anika Therapeutics, Inc. | 1,561,112 | 10.7% | EDGAR |
| SC 13D/A | 2024-03-06 | Caligan Partners LP | Anika Therapeutics, Inc. | 1,423,493 | 9.7% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Anika Therapeutics, Inc. | 764,045 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-09 | DIMENSIONAL FUND ADVISORS LP | Anika Therapeutics, Inc. | 821,452 | 5.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Trigran Investments, Inc. | Anika Therapeutics, Inc. | 2,139,054 | - | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Anika Therapeutics, Inc. | 1,383,877 | 9.5% | EDGAR |
| SC 13G/A | 2024-01-22 | STATE STREET CORP | Anika Therapeutics, Inc. | - | 2.1% | EDGAR |
| SC 13G/A | 2023-10-06 | BlackRock Inc. | Anika Therapeutics, Inc. | 1,416,135 | 9.7% | EDGAR |
| SC 13D/A | 2023-09-11 | Caligan Partners LP | Anika Therapeutics, Inc. | 1,081,360 | 7.4% | EDGAR |
| SC 13D | 2023-08-17 | Caligan Partners LP | Anika Therapeutics, Inc. | 902,086 | 6.2% | EDGAR |
| SC 13G/A | 2023-02-14 | AMERIPRISE FINANCIAL INC | Anika Therapeutics, Inc. | 181,943 | 1.2% | EDGAR |
| SC 13G/A | 2023-02-10 | DIMENSIONAL FUND ADVISORS LP | Anika Therapeutics, Inc. | 959,746 | 6.6% | EDGAR |
| SC 13G/A | 2023-02-10 | Trigran Investments, Inc. | Anika Therapeutics, Inc. | 1,564,541 | - | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Anika Therapeutics, Inc. | 983,768 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-08 | STATE STREET CORP | Anika Therapeutics, Inc. | - | 6.2% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | Anika Therapeutics, Inc. | 2,526,802 | 17.3% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | Anika Therapeutics, Inc. | 2,526,802 | 17.3% | EDGAR |
| SC 13G | 2022-10-07 | Trigran Investments, Inc. | Anika Therapeutics, Inc. | 1,493,245 | - | EDGAR |
| SC 13G/A | 2022-06-09 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | Anika Therapeutics, Inc. | 627,321 | 4.3% | EDGAR |
| SC 13G/A | 2022-02-14 | Avidity Partners Management LP | Anika Therapeutics, Inc. | 0 | 0.0% | EDGAR |